InvestorsHub Logo
Followers 22
Posts 1379
Boards Moderated 0
Alias Born 03/31/2017

Re: TradingPro post# 349492

Sunday, 02/28/2021 9:53:40 AM

Sunday, February 28, 2021 9:53:40 AM

Post# of 403741
Hopefully it will be obvious which patient got Brilacidin but I wonder if the double blinded was to slow down information leakage to the entity(s) that have been trying to destroy IPIX.

Go Leo & IPIX!

How is that comparable or fair in a double blinded trial that both the SOC and B arms wouldn’t be identical. To know which one to stop at 3 days would mean you knew which patients got B versus SOC. Just doesn’t make sense to me.


Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives FDA Fast Track Designation

Brilacidin in Phase 2 Clinical Trial of Innovation Pharmaceuticals - Brilacidin for Treating COVID-19.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News